190 related articles for article (PubMed ID: 27805249)
1. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
[TBL] [Abstract][Full Text] [Related]
2. Correlations of HACE1 expression with pathological stages, CT features and prognosis of hepatocellular carcinoma patients.
Zhang Z; Teng M; Xu Z; Wang D
J BUON; 2020; 25(6):2570-2575. PubMed ID: 33455098
[TBL] [Abstract][Full Text] [Related]
3. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC
Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma.
Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC
Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
12. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.
Uranbileg B; Enooku K; Soroida Y; Ohkawa R; Kudo Y; Nakagawa H; Tateishi R; Yoshida H; Shinzawa S; Moriya K; Ohtomo N; Nishikawa T; Inoue Y; Tomiya T; Kojima S; Matsuura T; Koike K; Yatomi Y; Ikeda H
Int J Cancer; 2014 May; 134(9):2189-98. PubMed ID: 24174293
[TBL] [Abstract][Full Text] [Related]
13. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
14. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
16. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.
Shimizu D; Kanda M; Sugimoto H; Shibata M; Tanaka H; Takami H; Iwata N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Int J Oncol; 2017 Feb; 50(2):381-386. PubMed ID: 28101581
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.
Yang X; Chen SL; Lin CS; Liu LL; Wang CH; Yun JP
Pathol Res Pract; 2020 Nov; 216(11):153153. PubMed ID: 32891822
[TBL] [Abstract][Full Text] [Related]
18. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
19. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
20. High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma.
Li Q; Ma Y; Xu W
Mol Med Rep; 2015 Jun; 11(6):4315-20. PubMed ID: 25634514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]